1108 related articles for article (PubMed ID: 19748873)
21. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services.
Branham AR; Katz AJ; Moose JS; Ferreri SP; Farley JF; Marciniak MW
J Pharm Pract; 2013 Aug; 26(4):420-7. PubMed ID: 23178415
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the economic impact of a targeted medication intervention program.
Rhodes SA; Reynolds AE; Marciniak MW; Ferreri SP
J Pharm Pract; 2013 Dec; 26(6):562-73. PubMed ID: 23804242
[TBL] [Abstract][Full Text] [Related]
25. Strategies for community-based medication management services in value-based health plans.
Smith MA; Spiggle S; McConnell B
Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
[TBL] [Abstract][Full Text] [Related]
27. Retrospective financial analysis of medication therapy management services from the pharmacy's perspective.
McDonough RP; Harthan AA; McLeese KE; Doucette WR
J Am Pharm Assoc (2003); 2010; 50(1):62-6. PubMed ID: 20097640
[TBL] [Abstract][Full Text] [Related]
28. Implementation of a medication therapy management program in a primary care clinic.
Bowers BL; Heffern C; Billings S
J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
[TBL] [Abstract][Full Text] [Related]
29. Development of a medication therapy management superbill for ambulatory care/community pharmacy practice.
Hogue MD; McDonough R; Bennett M; Bryner C; Thomas RA;
J Am Pharm Assoc (2003); 2009; 49(2):232-6. PubMed ID: 19289351
[TBL] [Abstract][Full Text] [Related]
30. Use of chronic disease management algorithms in Australian community pharmacies.
Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
[TBL] [Abstract][Full Text] [Related]
31. Estimated Potential Financial Impact of Pharmacist-Delivered Disease Management Services Across a Network of Pharmacies in Rural Colorado.
Nuffer W; Trujillo T; Griend JV
J Manag Care Spec Pharm; 2019 Sep; 25(9):984-988. PubMed ID: 31456492
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
[TBL] [Abstract][Full Text] [Related]
33. Pharmacy performance while providing continuous medication monitoring.
Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
[TBL] [Abstract][Full Text] [Related]
34. Implementation of a pharmacogenomics service in a community pharmacy.
Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical care in community pharmacies: practice and research in the US.
Christensen DB; Farris KB
Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
[TBL] [Abstract][Full Text] [Related]
36. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
Skelton JB; ;
J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
[TBL] [Abstract][Full Text] [Related]
37. Pay-for-performance model of medication therapy management in pharmacy practice.
Lenz TL; Monaghan MS
J Am Pharm Assoc (2003); 2011; 51(3):425-31. PubMed ID: 21555297
[TBL] [Abstract][Full Text] [Related]
38. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
Milfred-Laforest SK; Chow SL; Didomenico RJ; Dracup K; Ensor CR; Gattis-Stough W; Heywood JT; Lindenfeld J; Page RL; Patterson JH; Vardeny O; Massie BM
J Card Fail; 2013 May; 19(5):354-69. PubMed ID: 23663818
[TBL] [Abstract][Full Text] [Related]
39. Benefits of developing a collaborative, outcomes-based specialty pharmacy program.
Pulvermacher A; Nelson C
Am J Health Syst Pharm; 2016 Jun; 73(11):839-43. PubMed ID: 27126830
[TBL] [Abstract][Full Text] [Related]
40. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
Kalista T; Lemay V; Cohen L
J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
